2023 Q1 Form 10-Q Financial Statement

#000121390023002013 Filed on January 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $32.32M $9.877M $16.50M
YoY Change 70.25% -40.14% 15.56%
Cost Of Revenue $19.82M $14.80M $10.18M
YoY Change 74.8% 45.31% 17.33%
Gross Profit $12.49M $11.46M $6.318M
YoY Change 63.51% 81.37% 12.82%
Gross Profit Margin 38.66% 116.01% 38.29%
Selling, General & Admin $2.864M $1.513M $1.266M
YoY Change 50.63% 19.5% 15.11%
% of Gross Profit 22.92% 13.21% 20.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.864M $16.38M $1.162M
YoY Change 50.63% 1309.86% 5.62%
Operating Profit $9.629M -$4.921M $5.156M
YoY Change 67.77% -195.44% 14.58%
Interest Expense $10.63M -$3.917M $3.874M
YoY Change 261.2% -201.09% -32.74%
% of Operating Profit 110.4% 75.14%
Other Income/Expense, Net $1.280K
YoY Change
Pretax Income $19.88M $6.030M $8.266M
YoY Change 132.06% -27.05% -19.43%
Income Tax $676.9K $15.95K -$73.81K
% Of Pretax Income 3.41% 0.26% -0.89%
Net Earnings $19.20M $6.014M $8.340M
YoY Change 128.44% -27.89% 30.93%
Net Earnings / Revenue 59.42% 60.89% 50.54%
Basic Earnings Per Share $0.51 $0.73
Diluted Earnings Per Share $1.62 $0.51 $728.3K
COMMON SHARES
Basic Shares Outstanding 11.89M shares 11.90M shares 11.45M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.08M $47.05M $144.1M
YoY Change 81.72% -67.34% 324.98%
Cash & Equivalents $65.75M $5.672M $144.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $96.88M $47.88M $144.4M
YoY Change 81.99% -66.85% 276.13%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $116.3M $108.1M $661.8M
YoY Change -85.78% -83.67% 21.01%
Other Assets $531.3K $236.9K
YoY Change 108.38%
Total Long-Term Assets $981.3M $991.1M $667.3M
YoY Change 19.23% 48.53% 21.83%
TOTAL ASSETS
Total Short-Term Assets $96.88M $47.88M $144.4M
Total Long-Term Assets $981.3M $991.1M $667.3M
Total Assets $1.078B $1.039B $811.7M
YoY Change 23.04% 28.0% 38.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.58M $9.557M $12.08M
YoY Change 4.88% -20.89% 91.77%
Accrued Expenses $3.653M $79.12M $3.386M
YoY Change -95.29% 2236.52% 160.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.26M $88.71M $8.181M
YoY Change -78.92% 984.23% 7.65%
LONG-TERM LIABILITIES
Long-Term Debt $729.2M $627.1M $458.8M
YoY Change 66.98% 36.68% 65.51%
Other Long-Term Liabilities -$18.08M -$15.97M -$10.99M
YoY Change 46.6% 45.39%
Total Long-Term Liabilities $711.1M $611.1M $447.8M
YoY Change 67.57% 36.47% 61.54%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.26M $88.71M $8.181M
Total Long-Term Liabilities $711.1M $611.1M $447.8M
Total Liabilities $731.2M $703.2M $469.1M
YoY Change 40.49% 49.9% 63.91%
SHAREHOLDERS EQUITY
Retained Earnings $25.05M $13.95M
YoY Change -9.58%
Common Stock $321.9M $321.8M
YoY Change -1.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $347.0M $335.8M $342.6M
YoY Change
Total Liabilities & Shareholders Equity $1.078B $1.039B $811.7M
YoY Change 23.04% 28.0% 38.49%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $19.20M $6.014M $8.340M
YoY Change 128.44% -27.89% 30.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $32.56M -$22.46M $15.29M
YoY Change -122.27% -246.92% -147.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.16M
YoY Change -1766.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.47M 56.86M 55.47M
YoY Change -70.05% 2.51% 5929.26%
NET CHANGE
Cash From Operating Activities 32.56M -22.46M 15.29M
Cash From Investing Activities
Cash From Financing Activities 16.47M 56.86M 55.47M
Net Change In Cash 49.03M 34.40M 70.76M
YoY Change -153.76% -51.38% -324.63%
FREE CASH FLOW
Cash From Operating Activities $32.56M -$22.46M $15.29M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
sar Percentage Of Investments Weighted Average Spread
PercentageOfInvestmentsWeightedAverageSpread
0.038 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
814-00732
dei Entity Registrant Name
EntityRegistrantName
SARATOGA INVESTMENT CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8700615
dei Entity Address Address Line1
EntityAddressAddressLine1
535 Madison Avenue
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
(212)
dei Local Phone Number
LocalPhoneNumber
906-7800
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11890500 shares
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
776943715 usd
CY2022Q1 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
654965044 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
777907062 usd
CY2022Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
668358516 usd
CY2022Q4 us-gaap Investments In And Advances To Affiliates Balance Principal Amount
InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount
90180944 usd
CY2022Q1 us-gaap Investments In And Advances To Affiliates Balance Principal Amount
InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount
46224927 usd
CY2022Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
96051664 usd
CY2022Q1 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
48234124 usd
CY2022Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
119358478 usd
CY2022Q1 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
95058356 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
108075326 usd
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
100974715 usd
CY2022Q4 sar Amortized Cost Of Investment At Fair Value
AmortizedCostOfInvestmentAtFairValue
986483137 usd
CY2022Q1 sar Amortized Cost Of Investment At Fair Value
AmortizedCostOfInvestmentAtFairValue
796248327 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
982034052 usd
CY2022Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
817567355 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5672012 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47257801 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
41375630 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
5612541 usd
CY2022Q4 sar Net Reserve Of Interest Receivable
NetReserveOfInterestReceivable
1626140 usd
CY2022Q1 sar Net Reserve Of Interest Receivable
NetReserveOfInterestReceivable
0 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
8815596 usd
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
5093561 usd
CY2022Q1 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
90968 usd
CY2022Q4 sar Management Fee Receivable
ManagementFeeReceivable
363815 usd
CY2022Q1 sar Management Fee Receivable
ManagementFeeReceivable
362549 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236861 usd
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
254980 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
467632 usd
CY2022Q4 us-gaap Assets
Assets
1038965598 usd
CY2022Q1 us-gaap Assets
Assets
876239755 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
25000000 usd
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
12500000 usd
CY2022Q4 sar Base Management And Incentive Fees Payable
BaseManagementAndIncentiveFeesPayable
9556891 usd
CY2022Q1 sar Base Management And Incentive Fees Payable
BaseManagementAndIncentiveFeesPayable
12947025 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2139661 usd
CY2022Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
1249015 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1266008 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
799058 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
26836 usd
CY2022Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2820036 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4946725 usd
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2801621 usd
CY2022Q4 sar Directors Fees Payable
DirectorsFeesPayable
95932 usd
CY2022Q1 sar Directors Fees Payable
DirectorsFeesPayable
70000 usd
CY2022Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
6186 usd
CY2022Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
263814 usd
CY2022Q1 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
630183 usd
CY2022Q4 us-gaap Liabilities
Liabilities
703201998 usd
CY2022Q1 us-gaap Liabilities
Liabilities
520459232 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11885479 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11885479 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12131350 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12131350 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11885 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
12131 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
321802386 usd
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
328062246 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13949329 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27706146 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
335763600 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
355780523 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1038965598 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
876239755 usd
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
28.25
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.33
CY2022Q4 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
19549044 usd
CY2021Q4 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
11152851 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
49597660 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
33687612 usd
CY2022Q4 sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
1914800 usd
CY2021Q4 sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
1055947 usd
sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
4287449 usd
sar Interest Income On Affiliate Investments
InterestIncomeOnAffiliateInvestments
2332967 usd
CY2022Q4 sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
1671354 usd
CY2021Q4 sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
1702096 usd
sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
4731150 usd
sar Interest Income On Control Investments
InterestIncomeOnControlInvestments
5616182 usd
CY2022Q4 sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
87130 usd
CY2021Q4 sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
115724 usd
sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
258557 usd
sar Payment In Kind Interest Income On Non Control And Non Affiliate Investments
PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments
1002819 usd
CY2022Q4 sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
191860 usd
sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
221027 usd
CY2022Q4 sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
102720 usd
CY2021Q4 sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
110737 usd
sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
260161 usd
sar Payment In Kind Interest Income On Control Investments
PaymentInKindInterestIncomeOnControlInvestments
298383 usd
CY2022Q4 us-gaap Investment Income Net
InvestmentIncomeNet
23516908 usd
CY2021Q4 us-gaap Investment Income Net
InvestmentIncomeNet
14137355 usd
us-gaap Investment Income Net
InvestmentIncomeNet
59356004 usd
us-gaap Investment Income Net
InvestmentIncomeNet
42937963 usd
CY2022Q4 sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
200258 usd
CY2021Q4 sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
968 usd
sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
235410 usd
sar Interest From Cash And Cash Equivalents
InterestFromCashAndCashEquivalents
2561 usd
CY2022Q4 sar Management Fee Income
ManagementFeeIncome
818254 usd
CY2021Q4 sar Management Fee Income
ManagementFeeIncome
815739 usd
sar Management Fee Income
ManagementFeeIncome
2451242 usd
sar Management Fee Income
ManagementFeeIncome
2448593 usd
CY2022Q4 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
436941 usd
CY2021Q4 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
537621 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
949758 usd
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
1595119 usd
CY2022Q4 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
553497 usd
CY2021Q4 us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
582500 usd
us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
2813311 usd
us-gaap Investment Banking Advisory Brokerage And Underwriting Fees And Commissions
InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions
2922625 usd
CY2022Q4 us-gaap Other Income
OtherIncome
731166 usd
CY2021Q4 us-gaap Other Income
OtherIncome
427921 usd
us-gaap Other Income
OtherIncome
983277 usd
us-gaap Other Income
OtherIncome
1852916 usd
CY2022Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
26257024 usd
CY2021Q4 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
16502104 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
66789002 usd
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
51759777 usd
CY2022Q4 us-gaap Interest And Debt Expense
InterestAndDebtExpense
8449900 usd
CY2021Q4 us-gaap Interest And Debt Expense
InterestAndDebtExpense
4842900 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
23243438 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
14367996 usd
CY2022Q4 us-gaap Management Fee Expense
ManagementFeeExpense
4258821 usd
CY2021Q4 us-gaap Management Fee Expense
ManagementFeeExpense
2923676 usd
us-gaap Management Fee Expense
ManagementFeeExpense
12164989 usd
us-gaap Management Fee Expense
ManagementFeeExpense
8684681 usd
CY2022Q4 sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
1531060 usd
CY2021Q4 sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
2417628 usd
sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
216915 usd
sar Incentive Management Fees Expense Benefit
IncentiveManagementFeesExpenseBenefit
9698327 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
558531 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
-104438 usd
us-gaap Professional Fees
ProfessionalFees
1344021 usd
us-gaap Professional Fees
ProfessionalFees
863376 usd
CY2022Q4 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
818750 usd
CY2021Q4 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
750000 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
2341667 usd
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
2156250 usd
CY2022Q4 us-gaap General Insurance Expense
GeneralInsuranceExpense
89187 usd
CY2021Q4 us-gaap General Insurance Expense
GeneralInsuranceExpense
85399 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
266723 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
258035 usd
CY2022Q4 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
80000 usd
CY2021Q4 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
73096 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
300000 usd
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
265596 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
525202 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
357727 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1492063 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1301603 usd
CY2022Q4 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
68136 usd
CY2021Q4 us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
-40519 usd
us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
-132487 usd
us-gaap Other Income Tax Expense Benefit Continuing Operations
OtherIncomeTaxExpenseBenefitContinuingOperations
18082 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
16379587 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
11305469 usd
us-gaap Operating Expenses
OperatingExpenses
41237329 usd
us-gaap Operating Expenses
OperatingExpenses
37613946 usd
CY2022Q4 us-gaap Net Investment Income
NetInvestmentIncome
9877437 usd
CY2021Q4 us-gaap Net Investment Income
NetInvestmentIncome
5196635 usd
us-gaap Net Investment Income
NetInvestmentIncome
25551673 usd
us-gaap Net Investment Income
NetInvestmentIncome
14145831 usd
CY2022Q4 sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
-740434 usd
CY2021Q4 sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
2588468 usd
sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
7365913 usd
sar Realized Gain Loss From Affiliate Investments
RealizedGainLossFromAffiliateInvestments
6140073 usd
CY2021Q4 sar Affiliate Investments
AffiliateInvestments
7328457 usd
sar Affiliate Investments
AffiliateInvestments
7328457 usd
sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
-139867 usd
CY2022Q4 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-740434 usd
CY2021Q4 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
9916925 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7365913 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13328663 usd
CY2022Q4 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
479318 usd
CY2021Q4 sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
-2447173 usd
sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
548568 usd
sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
-2896056 usd
CY2022Q4 sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
2082634 usd
CY2021Q4 sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
3887216 usd
sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
-12430125 usd
sar Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
11593037 usd
CY2022Q4 sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
693483 usd
CY2021Q4 sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
-7412673 usd
sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
3861523 usd
sar Unrealized Appreciation Depreciation On Affiliate Investments
UnrealizedAppreciationDepreciationOnAffiliateInvestments
-1668686 usd
CY2022Q4 sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
-5952325 usd
CY2021Q4 sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
-2517159 usd
sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
-17199511 usd
sar Unrealized Appreciation Depreciation On Control Investments
UnrealizedAppreciationDepreciationOnControlInvestments
4222150 usd
CY2022Q4 sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-3176208 usd
CY2021Q4 sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-6042616 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-25768113 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
14146501 usd
CY2022Q4 us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
425848 usd
CY2021Q4 us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
-2480465 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
1017953 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
-921610 usd
CY2022Q4 sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
-3863172 usd
CY2021Q4 sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
3907601 usd
sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
-18871585 usd
sar Net Realized And Unrealized Gainloss On Investments
NetRealizedAndUnrealizedGainlossOnInvestments
25500718 usd
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-764123 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1204809 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2316263 usd
CY2022Q4 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
6014265 usd
CY2021Q4 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
8340113 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
5475279 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
37330286 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.3
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11893173 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11450861 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11989811 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11312991 shares
us-gaap Net Investment Income
NetInvestmentIncome
25551673 usd
us-gaap Net Investment Income
NetInvestmentIncome
14145831 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7365913 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13328663 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1204809 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2316263 usd
sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
548568 usd
sar Income Tax Provision Benefit From Realized Gain Loss On Investments
IncomeTaxProvisionBenefitFromRealizedGainLossOnInvestments
-2896056 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-25768113 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
14146501 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
1017953 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
-921610 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
5475279 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
37330286 usd
sar Investment Company Distribution To Shareholders
InvestmentCompanyDistributionToShareholders
-19232096 usd
sar Investment Company Distribution To Shareholders
InvestmentCompanyDistributionToShareholders
-15599129 usd
sar Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
-19232096 usd
sar Net Decrease In Net Assets From Shareholder Distributions
NetDecreaseInNetAssetsFromShareholderDistributions
-15599129 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15320818 usd
sar Investment Company Dividend Distributions
InvestmentCompanyDividendDistributions
3347802 usd
sar Investment Company Dividend Distributions
InvestmentCompanyDividendDistributions
2760278 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
9600116 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1252143 usd
sar Investment Company Capital Share Transactions Repurchase Fees
InvestmentCompanyCapitalShareTransactionsRepurchaseFees
7792 usd
sar Investment Company Capital Share Transactions Repurchase Fees
InvestmentCompanyCapitalShareTransactionsRepurchaseFees
992 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
143143 usd
sar Net Increase Decrease In Net Assets From Capital Share Transactions
NetIncreaseDecreaseInNetAssetsFromCapitalShareTransactions
-6260106 usd
sar Net Increase Decrease In Net Assets From Capital Share Transactions
NetIncreaseDecreaseInNetAssetsFromCapitalShareTransactions
16684818 usd
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-20016923 usd
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
38415975 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
355780523 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
304185770 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
335763600 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
342601745 usd
us-gaap Profit Loss
ProfitLoss
5475279 usd
us-gaap Profit Loss
ProfitLoss
37330286 usd
sar Paymentinkind And Other Adjustments To Cost
PaymentinkindAndOtherAdjustmentsToCost
1374899 usd
sar Paymentinkind And Other Adjustments To Cost
PaymentinkindAndOtherAdjustmentsToCost
-1120081 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1245358 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1368430 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2567903 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1544478 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1204809 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2316263 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-681055 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18082 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
7365913 usd
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
13328663 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
-25768113 usd
sar Net Change In Unrealized Appreciationdepreciation On Investments
NetChangeInUnrealizedAppreciationdepreciationOnInvestments
14146501 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
1017953 usd
us-gaap Investment Company Deferred Income Tax Unrealized Appreciation
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation
-921610 usd
sar Proceeds From Sales And Repayments Of Investments
ProceedsFromSalesAndRepaymentsOfInvestments
162090516 usd
sar Proceeds From Sales And Repayments Of Investments
ProceedsFromSalesAndRepaymentsOfInvestments
216236729 usd
sar Purchases Of Investments
PurchasesOfInvestments
345088953 usd
sar Purchases Of Investments
PurchasesOfInvestments
293753351 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
3722035 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
343168 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-90968 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-2719000 usd
sar Increase Decrease In Management And Incentive Fee Receivable
IncreaseDecreaseInManagementAndIncentiveFeeReceivable
1266 usd
sar Increase Decrease In Management And Incentive Fee Receivable
IncreaseDecreaseInManagementAndIncentiveFeeReceivable
330071 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18119 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
54299 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
467632 usd
sar Increase Decrease In Base Management And Incentive Fees Payable
IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable
3390134 usd
sar Increase Decrease In Base Management And Incentive Fees Payable
IncreaseDecreaseInBaseManagementAndIncentiveFeesPayable
-5524592 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
466950 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
210809 usd
sar Increase Decrease In Current Tax Payable
IncreaseDecreaseInCurrentTaxPayable
2793200 usd
sar Increase Decrease In Current Tax Payable
IncreaseDecreaseInCurrentTaxPayable
-2833988 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2145104 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
450550 usd
sar Increase Decrease In Directors Fees Payable
IncreaseDecreaseInDirectorsFeesPayable
-25932 usd
sar Increase Decrease In Directors Fees Payable
IncreaseDecreaseInDirectorsFeesPayable
70500 usd
sar Increase Decrease In Excise Tax Payable
IncreaseDecreaseInExciseTaxPayable
630183 usd
sar Increase Decrease In Excise Tax Payable
IncreaseDecreaseInExciseTaxPayable
691672 usd
sar Increase Decrease In Due To Manager
IncreaseDecreaseInDueToManager
257628 usd
sar Increase Decrease In Due To Manager
IncreaseDecreaseInDueToManager
-10887 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-162929180 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-56932682 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
105500000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
135000000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
35340000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
73500000 usd
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
163500000 usd
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
175000000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
43125000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
60000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7400318 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7768038 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-176000 usd
sar Discount On Debt Issuance On Notes
DiscountOnDebtIssuanceOnNotes
-360000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1250000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15320818 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
15884294 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
12838851 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
9600116 usd
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1252143 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7792 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-992 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
124714 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157106480 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
171086080 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5822700 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
114153398 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
52870342 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29915074 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47047642 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
144068472 usd
us-gaap Interest Paid Net
InterestPaidNet
18374593 usd
us-gaap Interest Paid Net
InterestPaidNet
12372967 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2770984 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
727469 usd
sar Paymentinkind Interest Income And Other Adjustments To Cost
PaymentinkindInterestIncomeAndOtherAdjustmentsToCost
1374899 usd
sar Paymentinkind Interest Income And Other Adjustments To Cost
PaymentinkindInterestIncomeAndOtherAdjustmentsToCost
1120081 usd
sar Net Accretion Of Discount On Investments
NetAccretionOfDiscountOnInvestments
1245358 usd
sar Net Accretion Of Discount On Investments
NetAccretionOfDiscountOnInvestments
1368430 usd
sar Amortization Of Deferred Debt Financing Costs
AmortizationOfDeferredDebtFinancingCosts
2567903 usd
sar Amortization Of Deferred Debt Financing Costs
AmortizationOfDeferredDebtFinancingCosts
1544478 usd
sar Stock Dividend Distribution
StockDividendDistribution
3347802 usd
sar Stock Dividend Distribution
StockDividendDistribution
2760278 usd
CY2022Q4 sar Money Market Shares
MoneyMarketShares
47047642 shares
CY2022Q4 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
47047642 usd
CY2022Q4 us-gaap Financial Instruments Owned Principal Investments At Fair Value
FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue
47047642 usd
CY2022Q4 sar Investment Owned Percentage
InvestmentOwnedPercentage
0.14 pure
CY2022Q1 sar Money Market Shares
MoneyMarketShares
52870342 shares
CY2022Q1 us-gaap Investment Owned Restricted Cost
InvestmentOwnedRestrictedCost
52870342 usd
CY2022Q1 us-gaap Financial Instruments Owned Principal Investments At Fair Value
FinancialInstrumentsOwnedPrincipalInvestmentsAtFairValue
52870342 usd
CY2022Q1 sar Investment Owned Percentage
InvestmentOwnedPercentage
0.149 pure
CY2022Q3 us-gaap Interest Expense Long Term Debt And Capital Securities
InterestExpenseLongTermDebtAndCapitalSecurities
175000000 usd
CY2022Q4 sar Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts
TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts
47047642 usd
CY2021Q4 sar Total Cash And Cash Equivalents And Cash And Cashs Equivalens Reserve Accounts
TotalCashAndCashEquivalentsAndCashAndCashsEquivalensReserveAccounts
144068471 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost
-1374000 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments
1245000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates in the Preparation of Financial Statements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
sar Aggregate Value Of Total Assets Percentage
AggregateValueOfTotalAssetsPercentage
0.05 pure
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
5672012 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
120881990 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
41375630 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
23186481 usd
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Transactions and Income Recognition</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At November 30, 2022, our investment in one portfolio company was on non-accrual status with a fair value of approximately $9.7 million, or 1.0% of the fair value of our portfolio. At February 28, 2022, there were no investments on non-accrual status.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325, <i>Investments-Other, Beneficial Interests in Securitized Financial Assets</i>, (“ASC 325”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q4 us-gaap Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status
FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatus
9700000 usd
sar Fair Value Option Loans Held As Assets Aggregate Percent In Non Accrual
FairValueOptionLoansHeldAsAssetsAggregatePercentInNonAccrual
0.01 pure
us-gaap Revenue Recognition Dividends
RevenueRecognitionDividends
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividend Income </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend income is recorded in the consolidated statements of operations when earned.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.35pt; text-indent: 22.1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p>
sar Investment Company Dividend Distribution Percentage
InvestmentCompanyDividendDistributionPercentage
0.20 pure
sar Investment Company Cash Distribution Percentage
InvestmentCompanyCashDistributionPercentage
0.20 pure
sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
-18454000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
340465000 usd
sar Minimum Distribute Percent To Qualify Ric
MinimumDistributePercentToQualifyRIC
0.90 pure
sar Nondeductible Us Federal Excise Tax
NondeductibleUSFederalExciseTax
0.04 pure
sar Minimum Ordinary Income Net Percentage Of Distribute
MinimumOrdinaryIncomeNetPercentageOfDistribute
0.98 pure
sar Minimum Capital Gain Income Net Percentage Of Distribute
MinimumCapitalGainIncomeNetPercentageOfDistribute
0.982 pure
sar Percentage Of Federal Excise Tax On Income
PercentageOfFederalExciseTaxOnIncome
0.04 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Management</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.</span></p>
CY2022Q4 sar First Lien Term Loans
FirstLienTermLoans
804242000 usd
sar Second Lien Term Loans
SecondLienTermLoans
23780000 usd
CY2022Q4 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
20599000 usd
sar Fair Valueof Structured Finance Securities
FairValueofStructuredFinanceSecurities
38900000 usd
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
94513000 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
982034000 usd
CY2022Q1 sar First Lien Term Loans
FirstLienTermLoans
631572000 usd
CY2022 sar Second Lien Term Loans
SecondLienTermLoans
44386000 usd
CY2022Q1 us-gaap Unsecured Long Term Debt
UnsecuredLongTermDebt
15931000 usd
CY2022 sar Fair Valueof Structured Finance Securities
FairValueofStructuredFinanceSecurities
38030000 usd
CY2022Q1 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
87648000 usd
CY2022Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
817567000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
805551000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
-162092000 usd
sar Net Realized Gainloss From Investments
NetRealizedGainlossFromInvestments
7366000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
972707000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-6190000 usd
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
554313000 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Adjustments To Cost
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAdjustmentsToCost
1121000 usd
sar Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Accretion Of Discount On Investments
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringAccretionOfDiscountOnInvestments
1368000 usd
sar Net Change In Unrealized Appreciation Depreciation On Investments
NetChangeInUnrealizedAppreciationDepreciationOnInvestments
14146000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
293754000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
-216237000 usd
sar Net Realized Gainloss From Investments
NetRealizedGainlossFromInvestments
13328000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
661793000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
15488000 usd
sar Fair Value Measurements Of Assets Unobservable Input
FairValueMeasurementsOfAssetsUnobservableInput
EBITDA Multiples (x)
sar Fair Value Measurements Of Assets Range
FairValueMeasurementsOfAssetsRange
5.7x  - 5.7x
sar Fair Value Measurements Of Assets Weighted Average
FairValueMeasurementsOfAssetsWeightedAverage
5.7x
CY2022Q4 sar Fair Value Measurement
FairValueMeasurement
972707000 usd
CY2022Q1 sar Fair Value Measurement
FairValueMeasurement
805551000 usd
CY2022Q4 sar Investments At Amortized Cost
InvestmentsAtAmortizedCost
986483000 usd
CY2022Q4 sar Amortized Cost Percentage Of Total Portfolio
AmortizedCostPercentageOfTotalPortfolio
1 pure
CY2022Q4 sar Total Investments At Fair Value
TotalInvestmentsAtFairValue
982034000 usd
CY2022Q4 sar Fair Value Percentage Of Total Portfolio
FairValuePercentageOfTotalPortfolio
1 pure
CY2022Q1 sar Investments At Amortized Cost
InvestmentsAtAmortizedCost
796248000 usd
CY2022Q1 sar Amortized Cost Percentage Of Total Portfolio
AmortizedCostPercentageOfTotalPortfolio
1 pure
CY2022Q1 sar Total Investments At Fair Value
TotalInvestmentsAtFairValue
817567000 usd
CY2022Q1 sar Fair Value Percentage Of Total Portfolio
FairValuePercentageOfTotalPortfolio
1 pure
sar Clo Member Valuation Model Inputs
CLOMemberValuationModelInputs
●Default rate: 2%   ● Recovery rate: 35% – 70%     ● Discount rate: 15.5% – 22%     ● Prepayment rate: 20%     ● Reinvestment rate / price: $97.00 for eighteen months; then L+365bps / $99.00  
sar Investment Represents Greater Than Five Percent Of Total Assets
InvestmentRepresentsGreaterThanFivePercentOfTotalAssets
0.05 pure
CY2018Q4 sar Legal Maturity Date
LegalMaturityDate
January 2030
CY2018Q4 sar Additional An Invested
AdditionalAnInvested
13800000 usd
CY2021Q1 sar Additional An Invested
AdditionalAnInvested
14000000 usd
CY2021Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
2600000 usd
CY2021Q3 sar Outstanding Receivable
OutstandingReceivable
2600000 usd
CY2021Q3 sar Percentage Owned And Managed
PercentageOwnedAndManaged
1 pure
CY2021Q3 sar Percentage Of Management Fee
PercentageOfManagementFee
0.001 pure
CY2021Q3 sar Percentage Subordinated Management Fee
PercentageSubordinatedManagementFee
0.004 pure
CY2021Q3 sar Percentage Of Excess Cash Flow
PercentageOfExcessCashFlow
0.20 pure
sar Management Fee Income
ManagementFeeIncome
2500000 usd
sar Management Fee Income
ManagementFeeIncome
2400000 usd
us-gaap Interest Income Other
InterestIncomeOther
1200000 usd
us-gaap Interest Income Other
InterestIncomeOther
3500000 usd
CY2022Q4 sar Investment Principal Balance
InvestmentPrincipalBalance
653300000 usd
sar Debt Principal Balance
DebtPrincipalBalance
611000000 usd
sar Percentage Of Debt Weighted Average Spread
PercentageOfDebtWeightedAverageSpread
0.022 pure
us-gaap Effect On Future Cash Flows Amount
EffectOnFutureCashFlowsAmount
19400000 usd
sar Investement Of Discount Rate
InvestementOfDiscountRate
0.22 pure
CY2022Q1 sar Investment Principal Balance
InvestmentPrincipalBalance
660200000 usd
CY2022 sar Percentage Of Investments Weighted Average Spread
PercentageOfInvestmentsWeightedAverageSpread
0.037 pure
CY2022 sar Debt Principal Balance
DebtPrincipalBalance
611000000 usd
CY2022 sar Percentage Of Debt Weighted Average Spread
PercentageOfDebtWeightedAverageSpread
0.022 pure
CY2022 us-gaap Effect On Future Cash Flows Amount
EffectOnFutureCashFlowsAmount
28700000 usd
CY2022 sar Investement Of Discount Rate
InvestementOfDiscountRate
0.15 pure
us-gaap Investment Income Interest
InvestmentIncomeInterest
1100000 usd
CY2023Q2 sar Unsecured Percentage
UnsecuredPercentage
0.07 pure
sar Owned Percentage
OwnedPercentage
1 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2350087 usd
CY2022Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1991241 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2311448 usd
CY2022Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1293496 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2178299 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1946761 usd
CY2022Q4 sar Net Deferred Tax Liability
NetDeferredTaxLiability
2139660 usd
CY2022Q1 sar Net Deferred Tax Liability
NetDeferredTaxLiability
1249016 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2200000 usd
CY2022Q4 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
400000 usd
CY2022Q4 sar Investment Company Deferred Income Tax Unrealized Appreciation1
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation1
500000 usd
CY2022Q4 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
100000 usd
CY2021Q4 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
2500000 usd
CY2021Q4 sar Investment Company Deferred Income Tax Unrealized Appreciation1
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation1
2400000 usd
CY2021Q4 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
40000.00 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
1000000 usd
sar Investment Company Deferred Income Tax Unrealized Appreciation1
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation1
500000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
100000 usd
us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
-900000 usd
sar Investment Company Deferred Income Tax Unrealized Appreciation1
InvestmentCompanyDeferredIncomeTaxUnrealizedAppreciation1
2900000 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
20000.00 usd
CY2022Q4 us-gaap Incentive Fee Expense
IncentiveFeeExpense
1500000 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
12200000 usd
CY2021Q4 us-gaap Management Fee Payable
ManagementFeePayable
8700000 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
3900000 usd
us-gaap Incentive Fee Expense
IncentiveFeeExpense
4800000 usd
CY2022Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
3700000 usd
CY2021Q4 us-gaap-sup Incentive Fee Payable
IncentiveFeePayable
4900000 usd
us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
4300000 usd
us-gaap Payment For Management Fee
PaymentForManagementFee
5300000 usd
CY2022Q1 us-gaap Payment For Management Fee
PaymentForManagementFee
3200000 usd
CY2022Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-255959 usd
CY2021Q4 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2157212 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-473475 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2583041 usd
CY2022Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-158721 usd
CY2021Q4 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
289961 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-80273 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
340655 usd
CY2022Q4 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-414680 usd
CY2021Q4 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2447173 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-553748 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2923696 usd
CY2022Q4 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
460531 usd
CY2021Q4 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1916842 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
844727 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-677986 usd
CY2022Q4 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-29901 usd
CY2021Q4 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-604143 usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
45917 usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-253182 usd
CY2022Q4 sar Net Deferred Expense
NetDeferredExpense
430629 usd
CY2021Q4 sar Net Deferred Expense
NetDeferredExpense
-2520985 usd
sar Net Deferred Expense
NetDeferredExpense
890645 usd
sar Net Deferred Expense
NetDeferredExpense
-931168 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15949 usd
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-73812 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
336896 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1992528 usd
us-gaap Management Fee Description
ManagementFeeDescription
The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters.
us-gaap Incentive Fee Description
IncentiveFeeDescription
Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20.0% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter.
us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.20 pure
CY2022Q4 us-gaap Management Fee Expense
ManagementFeeExpense
4300000 usd
CY2021Q4 us-gaap Management Fee Expense
ManagementFeeExpense
2900000 usd
CY2021Q4 us-gaap Incentive Fee Expense
IncentiveFeeExpense
2300000 usd
CY2022Q1 us-gaap Payment For Incentive Fee
PaymentForIncentiveFee
9800000 usd
sar Purchased Of Fair Value Percentage
PurchasedOfFairValuePercentage
0.875 pure
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
12250000
us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
25900000 usd
CY2019Q3 sar Additional Long Term Capital
AdditionalLongTermCapital
175000000 usd
CY2019Q3 sar Guaranteed Debentures Description
GuaranteedDebenturesDescription
With the third license approval, Saratoga can continue to grow its SBA relationship from $150.0 million to $350.0 million of committed capital.As of November 30, 2022, we have funded SBIC LP, SBIC II LP and SBIC III LP with an aggregate total of equity capital of $75.0 million, $87.5 million and $2.5 million, respectively, and have $242.7 million in SBA-guaranteed debentures outstanding, of which $67.7 million was held in SBIC LP, $175.0 million was held in SBIC II LP, and $0.0 million held in SBIC III LP. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP, SBIC II LP and SBIC III LP may borrow to a maximum of $150.0 million, $175.0 million, and $175.0 million, respectively, which is up to twice its potential regulatory capital. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.
us-gaap Debt Instrument Description
DebtInstrumentDescription
SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP, SBIC II LP and SBIC III LP may borrow to a maximum of $150.0 million, $175.0 million, and $175.0 million, respectively, which is up to twice its potential regulatory capital. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.
CY2022Q4 us-gaap Other Borrowings
OtherBorrowings
325000000 usd
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
48300000 usd
CY2013Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.075 pure
CY2015Q2 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
On May 29, 2015, the Company entered into a Debt Distribution Agreement with Ladenburg Thalmann & Co. Inc. through which the Company may offer for sale, from time to time, up to $20.0 million in aggregate principal amount of the 2020 Notes through an At-the-Market (“ATM”) offering. Prior to the 2020 Notes being redeemed in full, the Company had sold 539,725 2022 Notes with a principal of $13.5 million at an average price of $25.31 for aggregate net proceeds of $13.4 million (net of transaction costs). 
CY2020Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
24500000 usd
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
74500000 usd
us-gaap Assumption For Fair Value Of Interests Continued To Be Held By Transferor Servicing Assets Or Liabilities Prepayment Speed
AssumptionForFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrLiabilitiesPrepaymentSpeed
0.0625 pure
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
1500000 usd
CY2022Q4 us-gaap Derivative Variable Interest Rate
DerivativeVariableInterestRate
0.0625 pure
CY2022Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0625 pure
CY2022Q1 us-gaap General Fair Value Hedge Information Minimum R Square Percentage
GeneralFairValueHedgeInformationMinimumRSquarePercentage
0.0725 pure
CY2022Q4 us-gaap Short Term Debt Weighted Average Interest Rate Over Time
ShortTermDebtWeightedAverageInterestRateOverTime
0.0725 pure
CY2022Q4 us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0725 pure
us-gaap Short Term Debt Weighted Average Interest Rate Over Time
ShortTermDebtWeightedAverageInterestRateOverTime
0.0725 pure
us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.0725 pure
CY2022Q4 sar Indebtedness
Indebtedness
1000 usd
CY2019Q4 sar Redeemed Amount
RedeemedAmount
50000000 usd
CY2020Q1 sar Redeemed Amount
RedeemedAmount
24450000 usd
CY2019Q4 sar Aggregate Principal Amount
AggregatePrincipalAmount
74450000 usd
CY2021Q3 sar Aggregate Principal Amount
AggregatePrincipalAmount
60000000 usd
CY2021Q3 sar Percentage Of Aggregate Principal Amount Of Issued And Outstanding
PercentageOfAggregatePrincipalAmountOfIssuedAndOutstanding
0.0625 pure
CY2021Q3 sar Net Proceeds Percentage
NetProceedsPercentage
0.04375 pure
us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
0.0625 pure
CY2022Q3 sar Aggregate Principal Amount
AggregatePrincipalAmount
43100000 usd
CY2022Q3 sar Percentage Of Aggregate Principal Amount Of Issued And Outstanding
PercentageOfAggregatePrincipalAmountOfIssuedAndOutstanding
0.0725 pure
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
701160000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
77500000 usd
CY2022Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
88400000 usd
CY2022Q4 sar Off Balance Sheet Arrangements
OffBalanceSheetArrangements
77455000 usd
CY2022Q1 sar Off Balance Sheet Arrangements
OffBalanceSheetArrangements
83370000 usd
CY2022Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
47000000 usd
sar Directors Annual Fee
DirectorsAnnualFee
70000 usd
sar Board Meeting Attending Fee
BoardMeetingAttendingFee
3000 usd
sar Committee Meeting Attending Fee
CommitteeMeetingAttendingFee
1500 usd
sar Audit Committee Annual Fee
AuditCommitteeAnnualFee
12500 usd
sar Chairman Annual Fee
ChairmanAnnualFee
6000 usd
CY2022Q4 sar Directors Fees And Expenses
DirectorsFeesAndExpenses
100000 usd
CY2021Q4 sar Directors Fees And Expenses
DirectorsFeesAndExpenses
70000.00 usd
sar Directors Fees And Expenses
DirectorsFeesAndExpenses
300000 usd
sar Directors Fees And Expenses
DirectorsFeesAndExpenses
300000 usd
CY2022Q4 sar Directors Fee Payable
DirectorsFeePayable
100000 usd
CY2022Q1 sar Directors Fee Payable
DirectorsFeePayable
70000.00 usd
CY2010Q3 us-gaap Investments In And Advances To Affiliates Balance Shares
InvestmentsInAndAdvancesToAffiliatesBalanceShares
986842 shares
CY2010Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
15.2
CY2010Q3 sar Proceeds Received From Sales
ProceedsReceivedFromSales
15000000 usd
CY2010Q3 sar Total Cash Payment In Lieu Of Shares
TotalCashPaymentInLieuOfShares
230 usd
CY2010Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2680842 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.3
CY2014Q3 sar Description Of Repurchase Plan
DescriptionOfRepurchasePlan
On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). On October 7, 2015, our board of directors extended the Share Repurchase Plan for another year and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 400,000 shares of its common stock. On October 5, 2016, our board of directors extended the Share Repurchase Plan for another year to October 15, 2017 and increased the number of shares the Company is permitted to repurchase at prices below its NAV, as reported in its then most recently published consolidated financial statements, to 600,000 shares of its common stock. On October 10, 2017, January 8, 2019 and January 7, 2020, our board of directors extended the Share Repurchase Plan for another year to October 15, 2018, January 15, 2020 and January 15, 2021, respectively, each time leaving the number of shares unchanged at 600,000 shares of its common stock. On May 4, 2020, our board of directors increased the Share Repurchase Plan to 1.3 million shares of common stock. On January 5, 2021, our board of directors extended the Share Repurchase Plan for another year to January 15, 2022, leaving the number of shares unchanged at 1.3 million shares of common stock. On January 4, 2022, our board of directors extended the Shares Repurchase Plan for another year to January 15, 2023, leaving the number of shares unchanged at 1.3 million shares of common stock. As of November 30, 2022, the Company purchased 898,033 shares of common stock, at the average price of $21.65 for approximately $19.5 million pursuant to the Share Repurchase Plan. During the three months ended November 30, 2022 the Company purchased 94,071 shares of common stock, at the average price of $23.17 for approximately $2.1 million pursuant to the Share Repurchase Plan. During the nine months ended November 30, 2022 the Company purchased 389,598 shares of common stock, at the average price of $24.64 for approximately $9.6 million pursuant to the Share Repurchase Plan. 
CY2017Q1 sar Offer For Sale
OfferForSale
30000000 usd
CY2019Q3 sar Amount Of Common Stock
AmountOfCommonStock
70000000 usd
CY2019Q4 sar Amount Of Common Stock
AmountOfCommonStock
130000000 usd
CY2018Q3 sar Amount Of Common Stock
AmountOfCommonStock
1150000 usd
CY2018Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
25
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
28750000 usd
CY2018Q3 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million.
CY2018Q3 sar Excess Of Common Stock
ExcessOfCommonStock
172500 shares
CY2021Q3 sar Offer For Sale
OfferForSale
150000000 usd
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4840361 shares
sar Gross Proceeds
GrossProceeds
124000000 usd
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
25.61
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
122400000 usd
CY2022Q4 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
6014000 usd
CY2021Q4 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
8340000 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
5475000 usd
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
37330000 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11893173 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11450861 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11989811 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11312991 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2022Q4 us-gaap Dividends Cash
DividendsCash
6800000 usd
CY2022Q4 sar Stock Issued For Dividend
StockIssuedForDividend
53615 shares
CY2022Q4 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.005 pure
CY2022Q4 sar Stock Based Share Price
StockBasedSharePrice
24.26
CY2022Q4 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2022Q3 us-gaap Dividends Cash
DividendsCash
5300000 usd
CY2022Q3 sar Common Stock Dividend Rate Percentage
CommonStockDividendRatePercentage
0.004 pure
CY2022Q3 sar Stock Based Share Price
StockBasedSharePrice
22
CY2022Q3 sar Percentage Of Weighted Average Tradingprice
PercentageOfWeightedAverageTradingprice
0.95 pure
CY2022Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
1.75
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
20884000 usd
CY2021Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
1.92
CY2021Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
22032000 usd
CY2022Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.33
CY2021Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.25
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
2.13
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.25
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.57
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
2.25
sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.1
sar Investment Company Realized Losses On Extinguishment Of Debt
InvestmentCompanyRealizedLossesOnExtinguishmentOfDebt
-0.2
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
0.46
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
3.3
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.6
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.39
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.6
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.39
sar Investment Company Repurchases Of Commonstock
InvestmentCompanyRepurchasesOfCommonstock
0.15
sar Investment Company Repurchases Of Commonstock
InvestmentCompanyRepurchasesOfCommonstock
0.01
sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
-0.09
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
28.25
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
29.17
CY2022Q4 us-gaap Assets Net
AssetsNet
335763600 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
342601745 usd
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
11885479 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
11747004 shares
CY2022Q4 us-gaap-sup Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
26.37
CY2021Q4 us-gaap-sup Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
28.9
sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.0274 pure
sar Investment Company Total Returns Based On Market Value
InvestmentCompanyTotalReturnsBasedOnMarketValue
0.3225 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0298 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1303 pure
sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.099 pure
sar Investments Owned Percent Of Net Assets
InvestmentsOwnedPercentOfNetAssets
0.068 pure
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0702 pure
us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0619 pure
sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.0006 pure
sar Investment Company Expenses Ratio Including Incentive Fee
InvestmentCompanyExpensesRatioIncludingIncentiveFee
0.03 pure
sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.0897 pure
sar Investment Company Interest And Debt Financing Expenses To Average Net Assets
InvestmentCompanyInterestAndDebtFinancingExpensesToAverageNetAssets
0.059 pure
sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1605 pure
sar Investment Company Total Expense To Average Net Assets
InvestmentCompanyTotalExpenseToAverageNetAssets
0.1509 pure
sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.1777 pure
sar Portfolio Turnover Rate
PortfolioTurnoverRate
0.3379 pure
sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
1732 usd
sar Asset Coverage Ratio Per Units
AssetCoverageRatioPerUnits
2367 usd
sar Indebtedness Amount
IndebtednessAmount
1000 usd
us-gaap Line Of Credit Facility Description
LineOfCreditFacilityDescription
(12)The Revolving Credit Facility, SBA Debentures, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2027, 7.00% Notes Payable 2025 and 6.25% Notes Payable 2027 are not registered for public trading.
CY2021Q3 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
(13)On August 31, 2021, the Company redeemed $60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes and, as a result of the full redemption, the 6.25% 2025 Notes are no longer listed on the NYSE.
CY2022Q3 us-gaap Debt Instrument Redemption Description
DebtInstrumentRedemptionDescription
(14)On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.
dei Entity Central Index Key
EntityCentralIndexKey
0001377936
CY2022Q4 us-gaap Subsequent Event Description
SubsequentEventDescription
On December 13, 2022, the Company issued $52.5 million in aggregate principal amount of our 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.9 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. The Company has granted the underwriters an option to purchase up to an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year, beginning February 28, 2023.  The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. We expect to use the net proceeds from this offering to make investments in middle-market companies (including investments made through our SBIC subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $1.6 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note. 
CY2022Q4 us-gaap Subsequent Event Description
SubsequentEventDescription
On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. 
CY2022Q4 us-gaap Due From Affiliate Current
DueFromAffiliateCurrent
usd
CY2022Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
usd
sar Payment In Kind Interest Income On Affiliate Investments
PaymentInKindInterestIncomeOnAffiliateInvestments
usd
CY2022Q4 sar Affiliate Investments
AffiliateInvestments
usd
sar Affiliate Investments
AffiliateInvestments
usd
CY2022Q4 sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
usd
CY2021Q4 sar Realized Gain Loss From Control Investments
RealizedGainLossFromControlInvestments
usd
CY2022Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.30
CY2022Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11893173 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11989811 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
sar Discount On Debt Issuance On Notes
DiscountOnDebtIssuanceOnNotes
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
sar Investment Company Issuance Of Common Stock Above Net Asset Value
InvestmentCompanyIssuanceOfCommonStockAboveNetAssetValue
sar Investment Company Dilution Per Share
InvestmentCompanyDilutionPerShare
sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
sar Average Market Value Per Unit Of Revolving Credit Facility
AverageMarketValuePerUnitOfRevolvingCreditFacility
sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
sar Average Market Value Per Unit Of Small Business Administration Debentures Payable
AverageMarketValuePerUnitOfSmallBusinessAdministrationDebenturesPayable
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023

Files In Submission

Name View Source Status
0001213900-23-002013-index-headers.html Edgar Link pending
0001213900-23-002013-index.html Edgar Link pending
0001213900-23-002013.txt Edgar Link pending
0001213900-23-002013-xbrl.zip Edgar Link pending
f10q1122ex31-1_saratoga.htm Edgar Link pending
f10q1122ex31-2_saratoga.htm Edgar Link pending
f10q1122ex32-1_saratoga.htm Edgar Link pending
f10q1122ex32-2_saratoga.htm Edgar Link pending
f10q1122ex4-11_saratoga.htm Edgar Link pending
f10q1122ex4-6_saratoga.htm Edgar Link pending
f10q1122ex4-7_saratoga.htm Edgar Link pending
f10q1122_saratogainvest.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
f10q1122_saratogainvest_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sar-20221130.xsd Edgar Link pending
Show.js Edgar Link pending
sar-20221130_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sar-20221130_def.xml Edgar Link unprocessable
sar-20221130_pre.xml Edgar Link unprocessable
sar-20221130_lab.xml Edgar Link unprocessable